Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan Dmitrovsky

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Cancer Biology & Therapy|February 22, 2014
Mice lacking G0S2 are lean and cold-tolerantTian Ma, Alexandra G N Lopez-Aguiar, Aihua Li, et al.
Journal of Cellular Biochemistry|September 18, 2007
Cyclin degradation for cancer therapy and chemopreventionSarah J Freemantle, Xi Liu, Qing Feng, et al.
Analytical Chemistry|August 28, 2015
Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFRJa Hye Myung, Monic Roengvoraphoj, Kevin A Tam, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemiaSutisak Kitareewan, Ian Pitha-Rowe, David Sekula, et al.
Molecular Cancer Therapeutics|August 26, 2015
Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 KnockdownShanhu Hu, Yun Lu, Bernardo Orr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Evidence for the epidermal growth factor receptor as a target for lung cancer preventionFulvio Lonardo, Konstantin H Dragnev, Sarah J Freemantle, et al.
Cell Cycle (Georgetown, Tex.)|September 15, 2017
G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancerChristina Y Yim, Emmanuel Bikorimana, Ema Khan, et al.
Journal of the National Cancer Institute|November 17, 2005
A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesisW Jeffrey Petty, Na Li, Adrian Biddle, et al.
BMC Cancer|October 31, 2009
Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targetingGrace E Snow, Allison C Kasper, Alexander M Busch, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 17, 2007
Uncovering novel targets for cancer chemopreventionKonstantin H Dragnev, Qing Feng, Yan Ma, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Cancer Biology & Therapy|February 22, 2014
Mice lacking G0S2 are lean and cold-tolerantTian Ma, Alexandra G N Lopez-Aguiar, Aihua Li, et al.
Journal of Cellular Biochemistry|September 18, 2007
Cyclin degradation for cancer therapy and chemopreventionSarah J Freemantle, Xi Liu, Qing Feng, et al.
Analytical Chemistry|August 28, 2015
Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFRJa Hye Myung, Monic Roengvoraphoj, Kevin A Tam, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2002
UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemiaSutisak Kitareewan, Ian Pitha-Rowe, David Sekula, et al.
Molecular Cancer Therapeutics|August 26, 2015
Specific CP110 Phosphorylation Sites Mediate Anaphase Catastrophe after CDK2 Inhibition: Evidence for Cooperation with USP33 KnockdownShanhu Hu, Yun Lu, Bernardo Orr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Evidence for the epidermal growth factor receptor as a target for lung cancer preventionFulvio Lonardo, Konstantin H Dragnev, Sarah J Freemantle, et al.
Cell Cycle (Georgetown, Tex.)|September 15, 2017
G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancerChristina Y Yim, Emmanuel Bikorimana, Ema Khan, et al.
Journal of the National Cancer Institute|November 17, 2005
A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesisW Jeffrey Petty, Na Li, Adrian Biddle, et al.
BMC Cancer|October 31, 2009
Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targetingGrace E Snow, Allison C Kasper, Alexander M Busch, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 17, 2007
Uncovering novel targets for cancer chemopreventionKonstantin H Dragnev, Qing Feng, Yan Ma, et al.
Pageof 9